Practo appoints Jagnoor Singh CEO; Shashank ND Singh becomes executive chairman
Former COO Jagnoor Singh has been named CEO of Practo, while founder Shashank ND Singh moves to the role of managing director and executive chairman. The healthcare platform says it is growing 40% year on year and has been profitable for 2.5 years.
What happened
Practo appointed former COO Jagnoor Singh as CEO, while founder Shashank ND Singh became Managing Director and Executive Chairman. The healthcare platform said
Key facts
- 18 years
- January 2025
- 40% year-on-year growth
- 2.5 years profitable
Why this matters
A newly empowered operating CEO and sustained profitability could make Practo a more credible partnership or strategic transaction candidate in India’s healthcare platform market.
What to watch
- Whether Practo reports continued growth near or above 40% while preserving profitability.
- New hospital-chain, insurer, employer-health or diagnostics-network agreements.
- Changes in senior product, commercial, finance or clinical leadership following the CEO transition.
- Evidence of increased investment in new geographies, offline care infrastructure or acquisitions.
- Board, audit, governance and financial-disclosure upgrades consistent with eventual public-market preparation.
- Elevate senior leaders across provider partnerships, diagnostics, insurance, care delivery and product to support a broader operating structure.
- Prioritize profitable city-level expansion and cross-sell between doctor consultations, diagnostics, pharmacy-adjacent services and corporate health offerings.
- Pursue partnerships with hospital chains, insurers and employers that increase patient acquisition while lowering consumer marketing dependence.
- Use the profitability record and leadership succession to improve readiness for strategic fundraising, a pre-IPO governance buildout or selective acquisitions.
Also reported by
- YourStory — Same time